A. Malik

A. Malik

Chief U.S. Commercial Officer, EVPatPfizer· In proxies 2023–2025

Pay in FY2025+14% from the year before

A. Malik was paid $9.4M in FY2025 (Dec), up 14%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Pfizer proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PfizerPublic company · 3 yr
    • Chief U.S. Commercial Officer, EVP2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?